ArticleFrontiers in immunology2025

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment.

Hongfang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.